SlideShare a Scribd company logo

Nanotechnology update A seminar by Prof. Tatiana Tennikova

•Download as PPTX, PDF•
•
Attività scientifica
Attività scientifica

A seminar on nanotechnology at the Department of Surgical and Biomedical Science University of Perugia. The seminar will describe general concepts and biomedical applications of nanotechnologies.

Science
1 of 1
SEMINARIO DIPARTIMENTALE RELATORE: Prof. Tatiana Tennikova Institute of Macromolecular Compounds Russian Academy of Sciences St. Petersburg-Russia NANOTECHNOLOGY: GENERAL AND BIOMEDICAL APPLICATIONS Martedì 17 novembre 2015 ore 14,00 Scuola di Medicina e Chirurgia Università degli Studi di Perugia Aula 2 Edificio B (Piano -2) Introduzione Prof. Stefano Fiorucci UNIVERSITA' DEGLI STUDI DI PERUGIA Scuola di Medicina e Chirurgia Dipartimento di Scienze Chirurgiche e Biomediche Sezione di Gastroenterologia (Coordinatore Prof. Stefano Fiorucci)

Recommended

Seminario dipartimentale vaira
Seminario dipartimentale vairaSeminario dipartimentale vaira
Seminario dipartimentale vairaAttività scientifica
 
Convegno Neurologia
Convegno NeurologiaConvegno Neurologia
Convegno NeurologiaGianfranco Tammaro
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-Attività scientifica
 
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017Attività scientifica
 
PiezoFlags: Soluzione di Energy Harvesting per l'involucro.
PiezoFlags: Soluzione di Energy Harvesting per l'involucro.PiezoFlags: Soluzione di Energy Harvesting per l'involucro.
PiezoFlags: Soluzione di Energy Harvesting per l'involucro.carlo_cerve
 
Microbiota 2019
Microbiota 2019 Microbiota 2019
Microbiota 2019 Attività scientifica
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico Attività scientifica
 
Microbiota update perugia-
Microbiota update perugia- Microbiota update perugia-
Microbiota update perugia- Attività scientifica
 

Recommended

Seminario dipartimentale vaira
Seminario dipartimentale vairaSeminario dipartimentale vaira
Seminario dipartimentale vairaAttività scientifica
 
Convegno Neurologia
Convegno NeurologiaConvegno Neurologia
Convegno NeurologiaGianfranco Tammaro
 
NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-NAFLD/NASH - 3 febbraio 2017-
NAFLD/NASH - 3 febbraio 2017-Attività scientifica
 
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017
Ade 2018 emorragie Attività didattica integrativa 28 novembre 2017Attività scientifica
 
PiezoFlags: Soluzione di Energy Harvesting per l'involucro.
PiezoFlags: Soluzione di Energy Harvesting per l'involucro.PiezoFlags: Soluzione di Energy Harvesting per l'involucro.
PiezoFlags: Soluzione di Energy Harvesting per l'involucro.carlo_cerve
 
Microbiota 2019
Microbiota 2019 Microbiota 2019
Microbiota 2019 Attività scientifica
 
Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico Il punto sul microbiota e le malattie umane- Covegno scientifico
Il punto sul microbiota e le malattie umane- Covegno scientifico Attività scientifica
 
Microbiota update perugia-
Microbiota update perugia- Microbiota update perugia-
Microbiota update perugia- Attività scientifica
 
Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Attività scientifica
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleedingPortal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleedingAttività scientifica
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDAOcaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDAAttività scientifica
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro Attività scientifica
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Attività scientifica
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages Attività scientifica
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Attività scientifica
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability Attività scientifica
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosisDigestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosisAttività scientifica
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHAttività scientifica
 
New official web site
New official web siteNew official web site
New official web siteAttività scientifica
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016Attività scientifica
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Attività scientifica
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016Attività scientifica
 
Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016Attività scientifica
 
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSBILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSAttività scientifica
 
Research gate fiorucci citations
Research gate fiorucci citationsResearch gate fiorucci citations
Research gate fiorucci citationsAttività scientifica
 
Update emorragie digestive 2015
Update emorragie digestive 2015Update emorragie digestive 2015
Update emorragie digestive 2015Attività scientifica
 
Trends in Molecular Medicine
Trends in Molecular Medicine Trends in Molecular Medicine
Trends in Molecular Medicine Attività scientifica
 
Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015Attività scientifica
 

More Related Content

More from Attività scientifica

Portal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleedingPortal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleedingAttività scientifica
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDAOcaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDAAttività scientifica
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro Attività scientifica
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Attività scientifica
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages Attività scientifica
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Attività scientifica
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability Attività scientifica
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosisDigestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosisAttività scientifica
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHAttività scientifica
 
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSBILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSAttività scientifica
 

More from Attività scientifica (20)

Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018Microbiota perugia 20 aprile 2018
Microbiota perugia 20 aprile 2018
 
Portal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleedingPortal hypertension and gastrointestinal bleeding
Portal hypertension and gastrointestinal bleeding
 
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDAOcaliva causes 114 serious side effects and 24 deaths according to FDA
Ocaliva causes 114 serious side effects and 24 deaths according to FDA
 
Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro Metabolomic profile of the probiotic of VSL#3 in vitro
Metabolomic profile of the probiotic of VSL#3 in vitro
 
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
Nanomedecine - Just accepted for publication. Decoy receptor for CCR5
 
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
GPBAR1 (TGR5) regulates il 10 production from intestinal macrophages
 
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
Digestive Disease Week 2017 Discovery of dual LXR/GPBAR1
 
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
Digestive Disease Week 2017 The probiotic VSL#3 shows metabolic instability
 
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosisDigestive Disease Week 2017 BAR704 reduces liver fibrosis
Digestive Disease Week 2017 BAR704 reduces liver fibrosis
 
BAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASHBAR501 a selective TGR5 ligand attenuates NASH
BAR501 a selective TGR5 ligand attenuates NASH
 
New official web site
New official web siteNew official web site
New official web site
 
Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016Tgr5 and gastric cancer ddw2016
Tgr5 and gastric cancer ddw2016
 
Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016Bar501 and inflammation ddw 2016
Bar501 and inflammation ddw 2016
 
Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016Shp and liver fibrosis ddw 2016
Shp and liver fibrosis ddw 2016
 
Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016Ccr5 and colitis ddw 2016
Ccr5 and colitis ddw 2016
 
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONSBILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
BILE ACID ACTIVATED RECEPTORS: FROM MEDICINAL CHEMISTRY TO CLINICAL APPLICATIONS
 
Research gate fiorucci citations
Research gate fiorucci citationsResearch gate fiorucci citations
Research gate fiorucci citations
 
Update emorragie digestive 2015
Update emorragie digestive 2015Update emorragie digestive 2015
Update emorragie digestive 2015
 
Trends in Molecular Medicine
Trends in Molecular Medicine Trends in Molecular Medicine
Trends in Molecular Medicine
 
Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015Fiorucci’s lab sci report 2015
Fiorucci’s lab sci report 2015
 

Nanotechnology update A seminar by Prof. Tatiana Tennikova

  • 1. SEMINARIO DIPARTIMENTALE RELATORE: Prof. Tatiana Tennikova Institute of Macromolecular Compounds Russian Academy of Sciences St. Petersburg-Russia NANOTECHNOLOGY: GENERAL AND BIOMEDICAL APPLICATIONS Martedì 17 novembre 2015 ore 14,00 Scuola di Medicina e Chirurgia Università degli Studi di Perugia Aula 2 Edificio B (Piano -2) Introduzione Prof. Stefano Fiorucci UNIVERSITA' DEGLI STUDI DI PERUGIA Scuola di Medicina e Chirurgia Dipartimento di Scienze Chirurgiche e Biomediche Sezione di Gastroenterologia (Coordinatore Prof. Stefano Fiorucci)